ArticleBMJ nutrition, prevention & health2025
Pedalling towards better health: a randomised controlled trial of aerobic cycling to improve glycaemic control and quality of life in middle-aged men with type 2 diabetes.
Article in BMJ nutrition, prevention & health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: To evaluate the 3-month impact of aerobic cycling on metabolic health and quality of life in middle-aged men with type 2 diabetes in a randomised controlled trial. Method: A randomised controlled trial was conducted from July to November 2023 in five government hospitals in Lahore, Pakistan. A total of 120 male patients with type 2 diabetes mellitus (aged 50-65 years, body mass index (BMI) >25 kg/m², fasting plasma glucose (FPG) >140 mg/dL) were randomised into an exercise group (EG, n=60) and a control group (CG, n=60). The EG underwent a supervised aerobic cycling programme for 12 weeks (4 sessions/week, 50 min/session), while the CG continued usual care. Outcomes including BMI, weight, waist-to-hip ratio (WHR), FPG, blood pressure (BP), fat mass and Diabetes Quality of Life (DQOL) were measured preintervention and postintervention. Data were analysed using independent t-tests and multivariate regression (p<0.05). Results: 115 participants completed the study (eg,=55, CG=60). Postintervention, the EG showed significant reductions in FPG (154.6±22.6 vs 174.8±20.2 mg/dL; p=0.004), systolic BP (129.9±13.8 vs 145.2±16.8 mm Hg; p=0.003), diastolic BP (79.2±8.1 vs 82.0±8.8 mm Hg; p=0.022), fat mass (38.2%±7.1% vs 42.0%±6.2%; p=0.005) and WHR (1.0±0.1 vs 0.9±0.1; p=0.045). DQOL scores improved significantly in the EG (2.5±0.53) vs CG (3.5±1.2; p=0.004). Weight and BMI also decreased in the EG (p=0.047, p=0.053). Multivariate regression showed exercise as a significant predictor of weight loss (β=-1.5, p=0.004). Conclusions: A 3-month aerobic cycling programme significantly enhanced metabolic health and quality of life in middle-aged men with type 2 diabetes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.